Release Date: 2024-03-25

Bronchiectasis

Release Date: 2024-03-25

Bronchiectasis is defined as the permanent, chronic, and irreversible abnormal dilation of the airways.Bronchiectasis can result from a multitude of different underlying disorders, making the identification of its etiology crucial for guiding treatment.Patients commonly present with chronic cough, copious sputum production, and recurrent pneumonia attacks. The diagnosis of bronchiectasis is established through clinical and radiological [...]

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inThoracic Infections
First Page39
Last Page51
DOIhttps://doi.org/10.69860/nobel.9786053358930.5
ISBN978-605-335-893-0 (PDF)
LanguageENG
Page Count13
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
Bronchiectasis is defined as the permanent, chronic, and irreversible abnormal dilation of the airways.Bronchiectasis can result from a multitude of different underlying disorders, making the identification of its etiology crucial for guiding treatment.Patients commonly present with chronic cough, copious sputum production, and recurrent pneumonia attacks. The diagnosis of bronchiectasis is established through clinical and radiological findings. The objectives of treatment are to reduce recurrent pneumonia attacks, enhance quality of life, and halt disease progression.Bronchiectasis remains a common chronic lung disease that can affect the quality of life and expectancy of those affected. We recommend the surgical removal of affected lung regions in clinically selected patients.

Ibrahim Ethem Ozsoy (Author)
Associate Professor, Kayseri City Education and Research Hospital
https://orcid.org/0000-0003-2722-5309
3Assoc. Professor İbrahim Ethem Özsoy graduated from Eskişehir Osmangazi University Faculty of Medicine in 1998. He completed his thoracic surgery specialization training at Fırat University Faculty of Medicine in 2009. In 2021, he became an associate professor. He is currently continuing his academic studies, primarily focusing on lung cancers, in the Department of Thoracic Surgery at the Kayseri Faculty of Medicine, University of Health Sciences Türkiye. He has authored numerous original research articles and scientific book chapters in his field.

Mehmet Akif Ekici (Author)
Dr., Kayseri City Education and Research Hospital
https://orcid.org/0000-0002-4694-1047
3Dr. Mehmet Akif Ekici is a thoracic surgery specialist with a distinguished medical career. After graduating from Erciyes University Faculty of Medicine in 2006, he completed his thoracic surgery residency at Gaziantep University from 2017 to 2022. Since 2022, he has been serving as a thoracic surgery specialist at Kayseri City Hospital. His interests include tracheal stenosis, chest wall tumors, bronhiectasis, hydatid cysts, mediastinal masses, and EBUS. Dr. Ekici’s thesis focused on comparing D-valine effect in tracheal stenosis. He has published on various topics, including sequestration cases, omentum transposition, and spontaneous pneumothorax, continually advancing his expertise in thoracic surgery.

  • Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nature reviews Disease primers. 2018;4(1):45.

  • Aliberti S, Sotgiu G, Lapi F, Gramegna A, Cricelli C, Blasi F. Prevalence and incidence of bronchiectasis in Italy. BMC pulmonary medicine. 2020;20:1-6.

  • Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. American journal of respiratory and critical care medicine. 2000;162(4):1277-1284.

  • Huang H-Y, Chung F-T, Lo C-Y, et al. Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016. BMC Pulmonary Medicine. 2020;20:1-11.

  • Ravaglia C, Doglioni C, Chilosi M, et al. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. European Respiratory Journal. 2022;60(4)

  • Javidan-Nejad C, Bhalla S. Bronchiectasis. Radiologic Clinics of North America. 2009;47(2):289- 306.

  • Huang JT-J, Cant E, Keir HR, et al. Endotyping chronic obstructive pulmonary disease, bronchiectasis, and the “chronic obstructive pulmonary disease–bronchiectasis association”. American Journal of Respiratory and Critical Care Medicine. 2022;206(4):417-426.

  • Ramzi N, Jamee M, Bakhtiyari M, et al. Bronchiectasis in common variable immunodeficiency: a systematic review and meta‐analysis. Pediatric Pulmonology. 2020;55(2):292-299.

  • Cemal A, İNÖNÜ H, YÜKSEKKAYA R. Evaluation of pulmonary involvement in systemic rheumatic diseases with high resolution computed tomography and pulmonary function test: A single-center experience. Tuberk Toraks. 2021;69(2):125-132.

  • Metersky ML, Barker AF. The pathogenesis of bronchiectasis. Clinics in Chest Medicine. 2022;43(1):35-46.

  • Whitwell F. A study of the pathology and pathogenesis of bronchiectasis. Thorax. 1952;7(3):213.

  • Gudbjartsson T, Gudmundsson G. Middle lobe syndrome: a review of clinicopathological features, diagnosis and treatment. Respiration. 2012;84(1):80-86.

  • Cole P. Inflammation: a two-edged sword--the model of bronchiectasis. European journal of respiratory diseases Supplement. 1986;147:6-15.

  • King P. Pathogenesis of bronchiectasis. Paediatric respiratory reviews. 2011;12(2):104-110.

  • Barker AF. Bronchiectasis. New England Journal of Medicine. 2002;346(18):1383-1393.

  • Dhulappanavar C. Etiology and clinical profile in chronic cor pulmonale. International Journal of Advances in Medicine. 2020;7(1):168.

  • Martínez-García MÁ, Máiz L, Olveira C, et al. Normativa sobre el tratamiento de las bronquiectasias en el adulto. Archivos de Bronconeumología. 2018;54(2):88-98.

  • Van Der Bruggen-Bogaarts BA, Van Der Bruggen HM, Van Waes PF, Lammers J-WJ. Screening for bronchiectasis: a comparative study between chest radiography and high-resolution CT. Chest. 1996;109 (3):608-611.

  • Quaranta VN, Dragonieri S, Vulpi MR, et al. High level of blood eosinophils and localization of bronchiectasis in patients with severe asthma: a pilot study. Journal of Clinical Medicine. 2023;12(1):380.

  • Ferri S, Crimi C, Campisi R, et al. Impact of asthma on bronchiectasis severity and risk of exacerbations. Journal of Asthma. 2022;59 (3):469-475.

  • Chalmers JD. Cystic fibrosis lung disease and bronchiectasis. The Lancet Respiratory Medicine. 2020;8 (1):12-14.

  • Schlemmer F, Hamzaoui A, Zebachi S, et al. Etiological Work-Up for Adults with Bronchiectasis: A Predictive Diagnostic Score for Primary Ciliary Dyskinesia and Cystic Fibrosis. Journal of Clinical Medicine. 2021;10(16):3478.

  • Nucci MCNMd, Fernandes FLA, Salge JM, Stelmach R, Cukier A, Athanazio R. Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects. Jornal Brasileiro de Pneumologia. 2020;46

  • Nursoy MA, Kilinc AA, Abdillahi FK, et al. Relationships between bronchoscopy, microbiology, and radiology in noncystic fibrosis bronchiectasis. Pediatric allergy, immunology, and pulmonology. 2021;34(2):46-52.

  • Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. American journal of respiratory and critical care medicine. 2014;189(5):576-585.

  • MC P. British Thoracic Society Bronchiectasis (non-CF) Guideline Group: British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65:i1-i58.

  • Kelly C, Chalmers JD, Crossingham I, et al. Macrolide antibiotics for bronchiectasis. Cochrane Database of Systematic Reviews. 2018;(3)

  • Elborn JS, Blasi F, Haworth CS, et al. Bronchiectasis and inhaled tobramycin: a literature review. Respiratory medicine. 2022;192:106728.

  • Chang AB, Fortescue R, Grimwood K, et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. European respiratory journal. 2021;58(2)

  • Amegadzie JE, Gorgui J, Acheampong L, Gamble J-M, Farrell J, Gao Z. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis. Journal of Asthma. 2021;58(3):344-359.

  • O’Donnell AE. Airway clearance and mucoactive therapies in bronchiectasis. Clinics in Chest Medicine. 2022;43(1):157-163.

  • O’Donnell AE, Barker AF, Ilowite JS, Fick RB, Group rS. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest. 1998;113(5):1329-1334.

  • O’Neill K, O’Donnell AE, Bradley JM. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis. Respirology. 2019;24(3):227-237.

  • Fan L-C, Liang S, Lu H-W, Fei K, Xu J-F. Efficiency and safety of surgical intervention to patients with non-cystic fibrosis bronchiectasis: a meta-analysis. Scientific reports. 2015;5(1):17382.

  • Ashour M, Al-Kattan K, Jain S, et al. Surgery for unilateral bronchiectasis: results and prognostic factors. Tubercle and lung Disease. 1996;77(2):168-172

Share This Chapter!